CN Patent

CN108472297A — 手部湿疹的治疗

Assigned to Leo Pharma AS · Expires 2018-08-31 · 8y expired

What this patent protects

本发明涉及手部湿疹的治疗。本发明解决的问题在于提供3‑[(3S，4R)‑3‑甲基‑6‑(7H‑吡咯并[2，3‑d]嘧啶‑4‑基)‑1，6‑二氮杂螺[3.4]辛‑1‑基]‑3‑氧代丙腈的新药物用途。用于手部湿疹的治疗剂或预防剂包含3‑[(3S，4R)‑3‑甲基‑6‑(7H‑吡咯并[2，3‑d]嘧啶‑4‑基)‑1，6‑二氮杂螺[3.4]辛‑1‑基]‑3‑氧代丙腈作为活性成分。

USPTO Abstract

本发明涉及手部湿疹的治疗。本发明解决的问题在于提供3‑[(3S，4R)‑3‑甲基‑6‑(7H‑吡咯并[2，3‑d]嘧啶‑4‑基)‑1，6‑二氮杂螺[3.4]辛‑1‑基]‑3‑氧代丙腈的新药物用途。用于手部湿疹的治疗剂或预防剂包含3‑[(3S，4R)‑3‑甲基‑6‑(7H‑吡咯并[2，3‑d]嘧啶‑4‑基)‑1，6‑二氮杂螺[3.4]辛‑1‑基]‑3‑氧代丙腈作为活性成分。

Drugs covered by this patent

Patent Metadata

Patent number
CN108472297A
Jurisdiction
CN
Classification
—
Expires
2018-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Leo Pharma AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.